NOXAFIL

Merck Sharp & Dohme LLC🇺🇸 United States

FDA Page

Effective Date: Feb 13, 2026
Approval ID: b073b082-7b57-4423-8c06-4fd4263d6f84
Products: 4 registered
Version: 50

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NOXAFIL safely and effectively. See full prescribing information for NOXAFIL. NOXAFIL (posaconazole) injection, for intravenous use NOXAFIL (posaconazole) delayed-release tablets, for oral useNOXAFIL (posaconazole) oral suspensionNOXAFIL POWDERMIX (posaconazole) for delayed-release oral suspensionInitial U.S. Approval: 2006

Quick Stats

Total Products4

Labelers2

Label Sections43

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.